Centessa Pharmaceuticals plc (CNTA) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 9 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for CNTA is $38.60, representing a -2.5% downside from the current price of $39.59. Price targets range from a low of $35.00 to a high of $42.00.
